Health News Releases

  • Today December 16
November 18, 2021 11:50
Novvia Group Company, Inmark, Acquires a Majority Interest in Acepac Shanghai as It Sets to Expand Its Presence in Asia Pacific
Inmark, a Novvia Group company backed by Kelso & Company, has acquired a majority interest in the Shanghai operations of Acepac International, to support its Life Sciences Division. With their 10-year
November 17, 2021 09:06
Icure Acquires Drug Product Approval for World’s First Donepezil Patch for Treating Dementia of the Alzheimer Type in Korea
Icure Pharmaceutical Inc. (KOSDAQ: 175250), a biopharmaceutical company in Korea, announced today that its donepezil patch, a treatment of Alzheimer’s-type dementia, received a drug product approval f
November 17, 2021 02:00
Novel Blood Pressure Stabilization Therapy Presented at Neuroscience 2021
ONWARD Medical N.V. (Euronext: ONWD), a medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury, today announced Grégoi
November 16, 2021 13:50
BESREMi® (Ropeginterferon alfa-2b) approved by the US FDA
In 2009, AOP Orphan in-licensed the exclusive rights for clinical development and commercialization of Ropeginterferon alfa-2b in Polycythaemia Vera (PV), a rare disease, and other myeloproliferative
November 16, 2021 13:15
Theramex Enters OTC Market with Femarelle®, a Non-hormonal Option to Treat Menopause Symptoms
Theramex, a company dedicated women’s health, recently acquired the Femarelle® product licence to treat menopause symptoms. Femarelle will be available in different markets from the 2nd quarter of 202
November 16, 2021 11:35
New Study Finds That Use of Masimo SedLine® PSi and DSA May Significantly Reduce Postoperative Delirium
Masimo (NASDAQ: MASI) today announced the findings of a prospective study published in Frontiers in Neurology in which Dr. Na Xu and colleagues at Capital Medical University in Beijing investigated wh
November 15, 2021 17:05
Aimmune Therapeutics Presents New PALFORZIA® [Peanut (Arachis hypogaea) Allergen Powder-dnfp] Data on Immunological Outcomes of Long-Term Daily Oral Immunotherapy at the EAACI PAAM Digital Meeting
Aimmune Therapeutics, Inc., a Nestlé Health Science company developing and commercializing pharmaceutical therapies to prevent, manage, and treat food and metabolic-related diseases, today presented r
November 12, 2021 15:35
VFMCRP receives positive CHMP opinion for Tavneos® for the treatment of ANCA-associated vasculitis
Regulatory News: AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Vifor Fresenius Medical Care Renal Pharma (VFMCRP) today announced that the European Medicines Agency’s (EMA) CHMP has recommended app
November 12, 2021 13:45
Organon to Acquire Forendo Pharma
Organon (NYSE: OGN), and Forendo Pharma today announced that the companies have entered into a definitive agreement, under which Organon will acquire Forendo, a clinical-stage drug development company
November 12, 2021 13:20
Nuritas™ Raises $45 Million To Scale Its Peptide Discovery Platform And Expand Globally
Nuritas, a biotechnology company revolutionizing the discovery and development of plant-based bioactive peptides, has closed a $45 million USD Series B funding round. The investment, led by Chicago-ba
November 12, 2021 11:50
Clinical Study Shows ViroStop Spray Has Preventative Effect Against Covid-19
A recent clinical study has shown that the ViroStop nose and throat spray can have a preventative effect against Covid-19 infection, while at the same time boosting the body’s antibody response to the
November 11, 2021 15:45
25 Years of Making the World a Better Place for Women: Mary Kay Ash FoundationSM Marks Milestone Anniversary
In celebration of its 25th anniversary and guided by Mary Kay Ash’s dream to enrich the lives of women worldwide, the Mary Kay Ash FoundationSM released its first-ever Foundation Annual Report, as wel
November 11, 2021 11:30
Seven Healthcare Industry “High Reliability Organization Champions” Recognized by Patient Safety Movement Foundation
Medical errors claim the lives of nearly three million individuals across the globe every year. In any other high-risk industry, like aviation and nuclear power, these numbers would not be acceptable.
November 09, 2021 17:47
Yokogawa Acquires Insilico Biotechnology, Developer of Innovative Bioprocess Digital Twin Technology
Yokogawa Electric Corporation (TOKYO:6841) announces that it has acquired all shares of Insilico Biotechnology AG (“Insilico”), a Stuttgart, Germany-based developer and provider of bioprocess software
November 09, 2021 13:40
Rory McIlroy, Daniel Ricciardo, Connor McDavid, Klay Thompson, Jayson Tatum and More Join Naomi Osaka, Erling Haaland and Virat Kohli as Hyperice Athlete-Investors to Fuel Global Growth
Hyperice, a global high-performance wellness brand specializing in percussion, dynamic air compression, vibration, thermal technology, mind technology, and contrast therapy, today announced new invest
November 09, 2021 10:30
Masimo Root® with a Multimodal Brain Monitoring Algorithm May Improve Postoperative Neurocognition in Elderly Patients
Masimo (NASDAQ: MASI) today announced the findings of a prospective study published in Frontiers in Aging Neuroscience in which Dr. Shuyi Yang and colleagues at Capital Medical University in Beijing i
November 08, 2021 15:30
Empagliflozin shows consistent cardio-renal benefits in adults with heart failure with left ventricular ejection fraction over 40 percent regardless of chronic kidney disease status
Empagliflozin reduced the risk for the composite primary endpoint of cardiovascular death or hospitalization for heart failure and slowed kidney function decline in adults with heart failure with left
November 04, 2021 17:30
ENYO Pharma Announces Two Vonafexor Data Presentations at AASLD The Liver Meeting
ENYO Pharma (ENYO), a private clinical stage biotechnology company developing innovative drug candidates, today announced that two abstracts on Vonafexor were accepted one as oral presentation and one
NEOTENY got the world’s top three certifications including the ISO 21702, the CE Mark in Europe, and
November 04, 2021 10:09
NEOTENY Achieves World’s Top Three Certifications for its Antiviral Film ACLIV Killing COVID-19 Virus by 99.9% Within 30 Minutes
NEOTENY (CEO: Stewart Kim), a biotech company, announced that it has got the world’s top three certifications including the ISO 21702, the CE Mark in Europe, and the FDA approval in the U.S. for its a
November 03, 2021 13:35
PierianDx Closes up to $47.5 Million of Growth Capital
PierianDx, the global leader in clinical genomics knowledge, announced that it closed on $30 million of new growth capital including equity financing and a term loan facility, which includes access to
November 02, 2021 17:10
ReValve Solutions, Inc. Announces Successful First Human Use of the Transeptal Mitral Valve Replacement
ReValve Solutions, Inc., an innovator in the field of transcatheter structural heart replacement and repair, announced today it has successfully completed the first human use of its transcatheter, Pal
November 02, 2021 16:15
Nathan Jones, CEO of Xlear, Inc. Statement in Response to a Lawsuit Filed by the Department of Justice, on Behalf of the United States, Alleging That Certain Statements Made by Xlear Violated the FTC Act and the Consumer Protection Act
Today, Nathan Jones, CEO of Xlear, Inc. released this statement in response to a lawsuit filed by the Department of Justice, on behalf of the United States, alleging that certain statements made by Xl
November 02, 2021 15:30
Rhizen Pharmaceuticals AG Announces First Patient Dosing in a Phase I/Ib Study of Its Novel PARP Inhibitor (RP12146) in Patients With Advanced Solid Tumors
Rhizen Pharmaceuticals AG (Rhizen), a Switzerland-based privately held, clinical-stage oncology & inflammation-focused biopharmaceutical company, announced today that it has commenced dosing in a mult
November 02, 2021 14:10
Masimo Launches Dual SET® Pulse Oximetry
Masimo (NASDAQ: MASI) today announced Dual SET® Pulse Oximetry for Root®, a highly versatile patient monitoring and connectivity hub. The first application of Dual SET® Oximetry is a significant advan
November 02, 2021 11:20
Takeda Applied for Selection of “Prime Market”, Filed Corporate Governance Report With Tokyo Stock Exchange (TSE) in Line With Revised Corporate Governance Code and Published Corporate Governance Related Documents on its Website
Takeda Pharmaceutical Company Limited (TOKYO:4502/NYSE:TAK) (“Takeda”) today applied for selection of the “Prime Market” segment of the Tokyo Stock Exchange, Inc. (“TSE”) as its listing market as dete
25 per page50 per page75 per page100 per page